XML 21 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
Note 4 - Cash, Cash Equivalents and Marketable Securities
9 Months Ended
Sep. 30, 2022
Notes to Financial Statements  
Cash, Cash Equivalents, and Marketable Securities [Text Block]

4.

Cash, cash equivalents and marketable securities

 

The following is a summary of the Company's cash and cash equivalents as of the dates indicated:

 

  

September 30, 2022

  

December 31, 2021

 

Cash in banking institutions

 $1,276,935  $30,308,075 

Money market funds

  4,317,557   7,005,483 

Commercial paper

  992,526    

Total

 $6,587,018   37,313,558 

 

The following is a summary of the Company's marketable securities as of September 30, 2022:

 

  

Amortized cost

  

Unrealized gains

  

Unrealized losses

  

Fair Value

 

Commercial paper

 $15,357,565  $  $(56,985) $15,300,580 

U.S. treasury bonds

  4,000,330      (29,970)  3,970,360 

Total

 $19,357,895  $  $(86,955) $19,270,940 

 

The Company did not have any marketable securities as of December 31, 2021. The Company's marketable securities generally have contractual maturity dates between 3 and 12 months. All of the Company’s marketable securities are in an unrealized loss position at September 30, 2022. Unrealized losses on marketable securities as of September 30, 2022 were not significant and were primarily due to changes in interest rates, and not due to increased credit risks associated with specific securities. Accordingly, no other-than-temporary impairment was recorded for the nine months ended September 30, 2022 and there were no realized gains or losses recorded during the nine months ended September 30, 2021.